Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy of Multiple Brain Metastases Using AGuIX® Gadolinium-chelated Polysiloxane Based Nanoparticles: a Prospective Randomized Phase II Clinical Trial.

NCT03818386 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03818386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy of Multiple Brain Metastases Using AGuIX® Gadolinium-chelated Polysiloxane Based Nanoparticles: a Prospective Randomized Phase II Clinical Trial.
Lead sponsor
University Hospital, Grenoble
Phase
Phase 2
Overall status
Completed
Start date
March 26, 2019
Completion date
June 18, 2025
Enrollment
106 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult, radiotherapy